Kalvista Pharmaceuticals

KALV NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $7.21-$16.88
Market Cap $498.2M
Shares Short 5M

Financials

See more
Revenue (12 Mos) $3.8M
Revenue Growth (YoY) 30.7%
Gross Profit (12 Mos) -$80.2M
Diluted EPS -$3.12

About

CEO Mr. Benjamin L. Palleiko
Address 55 Cambridge Parkway, Cambridge, MA, United States, 02142
Sector Healthcare
Industry Biotechnology
Full-Time Employees 118